BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6491963)

  • 1. Determination of sodium levothyroxine in bulk, tablet, and injection formulations by high-performance liquid chromatography.
    Brower JF; Toler DY; Reepmeyer JC
    J Pharm Sci; 1984 Sep; 73(9):1315-7. PubMed ID: 6491963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversed-phase high-performance liquid chromatographic analysis of liothyronine sodium and levothyroxine sodium in tablet formulations: preliminary studies on dissolution and content uniformity.
    Rapaka RS; Knight PW; Prasad VK
    J Pharm Sci; 1981 Feb; 70(2):131-4. PubMed ID: 7205213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability-indicating assay, dissolution, and content uniformity of sodium levothyroxine in tablets.
    Richheimer SL; Amer TM
    J Pharm Sci; 1983 Nov; 72(11):1349-51. PubMed ID: 6644603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The separation and determination of liothyronine and levothyroxine in tablets by reversed-phase high performance liquid chromatography.
    Smith DJ; Biesemeyer M; Yaciw C
    J Chromatogr Sci; 1981 Feb; 19(2):72-8. PubMed ID: 7228964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic assay for sodium levothyroxine in tablet formulations: content uniformity applications.
    Garnick RL; Burt GF; Long DA; Bastian JW; Aldred JP
    J Pharm Sci; 1984 Jan; 73(1):75-7. PubMed ID: 6694088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of liothyronine and levothyroxine in thyroid preparations by liquid chromatography.
    Richheimer SL; Jensen CB
    J Pharm Sci; 1986 Feb; 75(2):215-7. PubMed ID: 3514844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and application of a validated HPLC method for the analysis of dissolution samples of levothyroxine sodium drug products.
    Collier JW; Shah RB; Bryant AR; Habib MJ; Khan MA; Faustino PJ
    J Pharm Biomed Anal; 2011 Feb; 54(3):433-8. PubMed ID: 20947276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients.
    Shah RB; Bryant A; Collier J; Habib MJ; Khan MA
    Int J Pharm; 2008 Aug; 360(1-2):77-82. PubMed ID: 18524511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid chromatographic determination of sulfasalazine in tablets and bulk powder.
    Egli KL
    J Assoc Off Anal Chem; 1985; 68(4):803-6. PubMed ID: 2863249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of high-performance liquid chromatography and radioimmunoassay in the determination of content uniformity of digoxin tablets.
    Beasley MW; Skierkowski P; Cleary RW; Jones AB; Kibbe AH
    J Pharm Sci; 1983 May; 72(5):505-8. PubMed ID: 6864496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are multisource levothyroxine sodium tablets marketed in Egypt interchangeable?
    Abou-Taleb BA; Bondok M; Nounou MI; Khalafallah N; Khalil S
    Ann Endocrinol (Paris); 2018 Feb; 79(1):23-29. PubMed ID: 29289332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High performance liquid chromatographic determination of clotrimazole in pharmaceutical formulations.
    Hoogerheide JG; Strusiak SH; Taddei CR; Townley ER; Wyka BE
    J Assoc Off Anal Chem; 1981 Jul; 64(4):864-9. PubMed ID: 7275902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse phase high pressure liquid chromatographic determination of some iodoamino acid contaminants in sodium liothyronine or sodium levothyroxine.
    Smith DJ; Graham JH
    J Assoc Off Anal Chem; 1979 Jul; 62(4):818-21. PubMed ID: 500533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability-indicating high performance liquid chromatographic method for determination of norfloxacin in bulk form and tablets.
    al-Deeb OA; Abdel-Moety EM; Abounassif MA; Alzaben SR
    Boll Chim Farm; 1995 Oct; 134(9):497-502. PubMed ID: 8527102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of excipients on the stability of levothyroxine sodium tablets.
    Das Gupta V; Odom C; Bethea C; Plattenburg J
    J Clin Pharm Ther; 1990 Oct; 15(5):331-6. PubMed ID: 2289935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of minoxidil in bulk drug and pharmaceutical formulations by ion-pairing high-performance liquid chromatography.
    Asmus PA; Landis JB; Grant ME; Havel HA
    J Pharm Sci; 1984 Sep; 73(9):1290-3. PubMed ID: 6491953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible leaching of diethyl phthalate into levothyroxine sodium tablets.
    Cafmeyer NR; Wolfson BB
    Am J Hosp Pharm; 1991 Apr; 48(4):735-9. PubMed ID: 2042676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatographic determination of prednisolone in tablets and bulk drugs: interlaboratory study.
    Brower JF
    J Assoc Off Anal Chem; 1984; 67(4):674-6. PubMed ID: 6469892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and method development of Tadalafil in bulk and tablet dosage form by RP-HPLC.
    Bojanapu A; Subramaniam AT; Munusamy J; Dhanapal K; Chennakesavalu J; Sellappan M; Jayaprakash V
    Drug Res (Stuttg); 2015 Feb; 65(2):82-5. PubMed ID: 24782284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of aspirin and salicylic acid in bulk aspirin and in plain, buffered, and enteric-coated tablets by high-pressure liquid chromatography with UV and fluorescence detectors.
    Kirchhoefer RD
    J Pharm Sci; 1980 Oct; 69(10):1188-91. PubMed ID: 7420289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.